Prolonged azathioprine treatment of non-remitting multiple sclerosis
- 1 April 1979
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 42 (4) , 338-344
- https://doi.org/10.1136/jnnp.42.4.338
Abstract
Two groups of 85 and 42 ambulatory patients with moderately advanced non-remitting multiple sclerosis were treated for six to 14 and three to six years with daily azathioprine. Less than 10% of these patients became confined to a wheelchair. This far exceeds any possible result in a group of non-remitting multiple sclerosis patients not so treated.This publication has 29 references indexed in Scilit:
- MULTIPLE SCLEROSIS: A TWO-PHASE DISEASE?Acta Neurologica Scandinavica, 2009
- THE COURSE OF MULTIPLE SCLEROSISActa Neurologica Scandinavica, 2009
- Cyclophosphamide in exacerbations of multiple sclerosis. Therapeutic trial and a strategy for pilot drug studies.Journal of Neurology, Neurosurgery & Psychiatry, 1975
- LINOLEIC ACID AS AN IMMUNOSUPPRESSIVE AGENTThe Lancet, 1975
- Long-term treatment of multiple sclerosis with azathioprineJournal of Neurology, Neurosurgery & Psychiatry, 1973
- HL-A ANTIGENS AND MULTIPLE SCLEROSISPublished by Elsevier ,1972
- PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSISAnnals of the New York Academy of Sciences, 1965
- PROGNOSTIC CRITERIA IN MULTIPLE SCLEROSISAnnals of the New York Academy of Sciences, 1965
- EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: THE EFFECT OF 6-MERCAPTOPURINEThe Journal of Experimental Medicine, 1962
- SURVIVAL IN DISSEMINATED SCLEROSIS: A CLINICAL STUDY OF A SERIES OF CASES FIRST SEEN TWENTY YEARS AGOBrain, 1950